Skip to contentG
GE HealthCare Technologies Inc.
G
GEHCGE HealthCare Technologies Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.70B$5.70Bderived+7.1% vs Q4 2024 Net Income$588.00M$588.00Mderived−18.4% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,261,000,000−0.6% Operating Incomederived$827,000,000+3.2% Operating Cash Flowderived$1,050,000,000+15.0% Free Cash Flowderived$916,000,000+12.9% Margins · derivedGross margin39.7%−3.1 pt vs Q4 2024
Operating margin14.5%−0.5 pt vs Q4 2024
Net margin10.3%−3.2 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 4, 2026 · 35 d after period end